Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 5/2016

01-05-2016 | Correspondence

In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma

Authors: Marina Bianchi, Antonio Clavenna, Daniele Piovani, Maurizio Bonati

Published in: European Journal of Epidemiology | Issue 5/2016

Login to get access

Excerpt

We read with interest the article by Pitter et al. [1], in which an association was found between antibiotics therapy during the first year of life and an increased risk of subsequent treatment-required asthma. The association between early exposure to antibiotics and asthma is still debated, however, in our opinion the study by Pitter et al. has a relevant limitation. Healthcare databases can be a valuable tool for monitoring diseases, and in this regard strategies for estimating asthma prevalence have been developed, also in Italian context [2]. …
Literature
1.
Pitter G, Ludvigsson JF, Romor P, Zanier L, Zanotti R, Simonato L, Canova C. Antibiotic exposure in the first year of life and later treated asthma, a population based birth cohort study of 143,000 children. Eur J Epidemiol. 2016;31:85–94.CrossRefPubMed
2.
Bianchi M, Clavenna A, Sequi M, Bortolotti A, Fortino I, Merlino L, Bonati M. Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new user. BMC Pulm Med. 2011;11:48.CrossRefPubMedPubMedCentral
3.
Pandolfini C, Campi R, Clavenna A, Cazzato T, Bonati M. Italian paediatricians and off-label prescriptions: loyal to regulatory or guideline standards. Acta Paediatr. 2005;94:753–7.CrossRefPubMed
4.
Sen EF, Verhamme KM, Neubert A, Hsia Y, Murray M, Felisi M, Giaquinto C, ‘t Jong GW, Picelli G, Baraldi E, Nicolosi A, Ceci A, Wong IC, Sturkenboom MC. TEDDY European Network of Excellence. Assessment of pediatric asthma drug use in three European countries; a TEDDY study. Eur J Pediatr. 2011;170:81.CrossRefPubMed
5.
Bianchi M, Clavenna A, Sequi M, Bonati M. Asthma diagnosis vs. analysis of anti-asthmatic prescriptions. Eur J Clin Pharmacol. 2011;67:967–8.CrossRefPubMed
Metadata
Title
In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma
Authors
Marina Bianchi
Antonio Clavenna
Daniele Piovani
Maurizio Bonati
Publication date
01-05-2016
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 5/2016
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-016-0146-6

Other articles of this Issue 5/2016

European Journal of Epidemiology 5/2016 Go to the issue

PERINATAL EPIDEMIOLOGY

Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden

COMMENTARY

Disengaging from statistical significance

REVIEW

Epilepsy, excess deaths and years of life lost from external causes

DEVELOPMENTAL EPIDEMIOLOGY

Associations between early body mass index trajectories and later metabolic risk factors in European children: the IDEFICS study

MORTALITY

Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES)

Correspondence

Reply to Bianchi et al.: In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma